[Exacerbation of catatonic symptoms in neuroleptic therapy].
This paper deals with the worsening of catatonic symptoms in three schizophrenic patients treated with typical neuroleptics. The paranoid and/or hallucinatory symptoms were positively influenced, but all patients showed marked subjective and objective sensitivity to this treatment regimen. As demonstrated in the three case reports, the diagnostic assessment of catatonic motor expressions movement and speech before initiation of pharmacotherapy can facilitate the differentiation between morbogenic and pharmacogenic movement disorders.
Bräunig
P
P
Zentrum für Psychiatrie, Ruhr-Universität Bochum.
Krüger
S
S
Höffler
J
J
D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis / Q000523:psychology; D006801:Humans; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D011569:Psychiatric Status Rating Scales; D012008:Recurrence; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012560:Schizophrenia, Catatonic / Q000139:chemically induced* / Q000175:diagnosis; D012565:Schizophrenic Psychology